Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only

H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th ...

Headsafe Enters U.S. Healthcare Market with FDA-Cleared Concussion Assessment Device

Lightweight portable system delivers fast, precise, objective data for rapid aid in diagnosis of concussions in ...
Nasdaq

BlinkLab Unveils AI-Powered Neurological Testing Platform

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Ophthalmology Times

IGS 2026: Considering OCT in neuro-ophthalmology and neurological diseases

At the 2nd International Glaucoma Symposium in Mainz, Germany, on 31 January 2026, optical coherence tomography (OCT) and its role in glaucoma and neuro-ophthalmic disease took centre stage in a ...
Nasdaq

Avail Scientific Signs LOI to Acquire Florida Neurological Testing Company Relai Neuro

TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which ...
BMJ Case Reports

Acute neurological Behçet’s disease complicated by a syndrome of inappropriate secretion of antidiuretic hormone

We report a rare case of acute neurological Behçet’s disease (neuro-BD) diagnosed concurrently with systemic Behçet’s disease ...